121 related articles for article (PubMed ID: 5391106)
1. Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy.
Alexanderson B; Evans DA; Sjöqvist F
Br Med J; 1969 Dec; 4(5686):764-8. PubMed ID: 5391106
[TBL] [Abstract][Full Text] [Related]
2. Maturing pharmacogenomic factors deliver improvements and cost efficiencies.
Jarvis JP; Megill SE; Silvester P; Shaman JA
Camb Prism Precis Med; 2023; 1():e3. PubMed ID: 38550951
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomic and Statistical Analysis.
Bai H; Zhang X; Bush WS
Methods Mol Biol; 2023; 2629():305-330. PubMed ID: 36929083
[TBL] [Abstract][Full Text] [Related]
4. Reflections on the Lack of Consideration of Ethnic Ancestry to Stratify Clozapine Dosing.
de Leon J
Psychiatry Investig; 2023 Mar; 20(3):183-195. PubMed ID: 36850057
[TBL] [Abstract][Full Text] [Related]
5. Segmental duplications and their variation in a complete human genome.
Vollger MR; Guitart X; Dishuck PC; Mercuri L; Harvey WT; Gershman A; Diekhans M; Sulovari A; Munson KM; Lewis AP; Hoekzema K; Porubsky D; Li R; Nurk S; Koren S; Miga KH; Phillippy AM; Timp W; Ventura M; Eichler EE
Science; 2022 Apr; 376(6588):eabj6965. PubMed ID: 35357917
[TBL] [Abstract][Full Text] [Related]
6. Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity.
Lauschke VM; Zhou Y; Ingelman-Sundberg M
Pharmacol Ther; 2019 May; 197():122-152. PubMed ID: 30677473
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacology in Stockholm 50 years-report from the jubilee symposium.
Eichelbaum M; Dahl ML; Sjöqvist F
Eur J Clin Pharmacol; 2018 Jun; 74(6):843-851. PubMed ID: 29487959
[No Abstract] [Full Text] [Related]
8. Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing.
Yang Y; Botton MR; Scott ER; Scott SA
Pharmacogenomics; 2017 May; 18(7):673-685. PubMed ID: 28470112
[TBL] [Abstract][Full Text] [Related]
9. Impact of age on serum concentrations of venlafaxine and escitalopram in different CYP2D6 and CYP2C19 genotype subgroups.
Waade RB; Hermann M; Moe HL; Molden E
Eur J Clin Pharmacol; 2014 Aug; 70(8):933-40. PubMed ID: 24858822
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options.
Drozda K; Müller DJ; Bishop JR
Pharmacotherapy; 2014 Feb; 34(2):166-84. PubMed ID: 24523097
[TBL] [Abstract][Full Text] [Related]
11. Genetics of adverse reactions to haloperidol in a mouse diallel: a drug-placebo experiment and Bayesian causal analysis.
Crowley JJ; Kim Y; Lenarcic AB; Quackenbush CR; Barrick CJ; Adkins DE; Shaw GS; Miller DR; de Villena FP; Sullivan PF; Valdar W
Genetics; 2014 Jan; 196(1):321-47. PubMed ID: 24240528
[TBL] [Abstract][Full Text] [Related]
12. Effects of gender and age on serum concentrations of antidepressants under naturalistic conditions.
Unterecker S; Riederer P; Proft F; Maloney J; Deckert J; Pfuhlmann B
J Neural Transm (Vienna); 2013 Aug; 120(8):1237-46. PubMed ID: 23254926
[TBL] [Abstract][Full Text] [Related]
13. The assessment of potential drug interactions with a new tricyclic antidepressant drug.
Briant RH; George CF
Br J Clin Pharmacol; 1974 Apr; 1(2):113-8. PubMed ID: 22454897
[TBL] [Abstract][Full Text] [Related]
14. The effect of fluphenazine on steady state plasma levels of nortriptyline.
Stevenson IH; Schiff AA
Br J Clin Pharmacol; 1974 Aug; 1(4):337-8. PubMed ID: 22454890
[No Abstract] [Full Text] [Related]
15. Plasma concentrations of tricyclic antidepressive drugs.
Lader M
Br J Clin Pharmacol; 1974 Aug; 1(4):281-3. PubMed ID: 22454878
[No Abstract] [Full Text] [Related]
16. Clinically relevant genetic variations in drug metabolizing enzymes.
Pinto N; Dolan ME
Curr Drug Metab; 2011 Jun; 12(5):487-97. PubMed ID: 21453273
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy.
Gervasini G; Benítez J; Carrillo JA
Eur J Clin Pharmacol; 2010 Aug; 66(8):755-74. PubMed ID: 20582584
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.
Zhou SF
Clin Pharmacokinet; 2009; 48(11):689-723. PubMed ID: 19817501
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatry.
Hiemke C
Eur J Clin Pharmacol; 2008 Feb; 64(2):159-66. PubMed ID: 18196227
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring of nortriptyline in smoking cessation: a multistudy analysis.
Mooney ME; Reus VI; Gorecki J; Hall SM; Humfleet GL; Muñoz RF; Delucchi K
Clin Pharmacol Ther; 2008 Mar; 83(3):436-42. PubMed ID: 17687275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
